Drugs / AR-14034
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05769153 | Dec 2023 → May 2027 expected | wet macular degeneration | Alcon Research | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AR-14034 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05769153 ↗ |
| Route | Intravitreal | “AR-14034 SR administered as an intravitreal implant” NCT05769153 ↗ |